Streetbeat News

ALTM

Arcadium Lithium plc

Industry

Chemicals - Specialty

Arcadium Lithium plc engages in the production of lithium chemicals products in the Asia Pacific, North America, Europe, the Middle East, Africa, and Latin America. The company offers battery-grade lithium hydroxide, lithium carbonate, butyllithium and high purity lithium metal for electric vehicles, greases, polymers, pharmaceutical, battery, and aerospace applications. It also owns 100% interest in the Sal de Vida property located in Argentina; the Cauchari property located in Argentina; the James Bay property located in northwestern Quebec, Canada; the Salar Del Hombre Muerto property located in Argentina; Mt Cattlin property located in Western Australia; owns 66.5% interest in the Salar de Olaroz property located in Jujuy Province, Argentina; and owns 50% interest in the Whabouchi Mine property located in Canada. The company was founded in 1944 and is based in Shannon, Ireland.

Open

5.25

Mkt cap

5.6B

Volume

14M

High

5.26

P/E Ratio

29.00

52-wk high

7.80

Low

5.21

Div yield

N/A

52-wk low

2.19

Arcadium Lithium (NYSE:ALTM) shares surged over 30% after announcing a definitive agreement to be acquired by Rio Tinto in an all-cash deal valued at $6.7 billion, representing a 90% premium to its previous closing price. The acquisition aims to integrate Arcadium's lithium business into Rio Tinto's portfolio, enhancing its focus on energy transition commodities.

Portfolio Pulse from Adam Eckert

October 09, 2024 | 1:08 pm

Arcadium Lithium shares surged following the announcement of its acquisition by Rio Tinto.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 12:19 pm

US stock futures indicate a marginally lower opening, with Nvidia gaining in premarket trading. Traders are focused on the Federal Reserve's meeting minutes and upcoming economic data. Nvidia's rise is attributed to positive demand commentary for its chips. The bull market is nearing its second anniversary, with expectations of continued gains.

Portfolio Pulse from Shanthi Rexaline

October 09, 2024 | 11:29 am

Rio Tinto has announced a $6.7 billion acquisition of Arcadium Lithium, a major Tesla supplier, in an all-cash deal. This acquisition positions Rio Tinto as a leader in the lithium market, crucial for the energy transition. Arcadium's shares surged over 30% pre-market, while Rio Tinto's shares dipped slightly.

Portfolio Pulse from Pooja Rajkumari

October 09, 2024 | 10:39 am

Saratoga Investment Corp. (NYSE:SAR) shares rose 7.9% in pre-market trading after reporting better-than-expected earnings. Other notable pre-market movers include Carmell Corporation, WW International, and Arcadium Lithium, with significant gains, while Paltalk, Kidpik, and Moolec Science saw declines.

Portfolio Pulse from Avi Kapoor

October 09, 2024 | 9:32 am

Rio Tinto is set to acquire Arcadium Lithium for $6.7 billion at $5.85 per share, enhancing its position in the global lithium market. This acquisition aligns with Rio Tinto's strategy to expand in high-growth markets and leverage its project development capabilities.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 5:58 am

U.S. stocks fell on Monday, with the Dow dropping over 400 points. Duckhorn Portfolio shares surged 104% after announcing better-than-expected financial results and an acquisition agreement. Scholar Rock shares rose 328% following positive clinical trial results. AstraZeneca entered a licensing agreement with CSPC Pharmaceutical. Trevena shares fell 46% after a Nasdaq delisting notification.

Portfolio Pulse from Avi Kapoor

October 07, 2024 | 6:37 pm

Arcadium Lithium (NYSE:ALTM) has received mixed analyst ratings, with a decrease in the average 12-month price target from $5.26 to $4.59. The company shows strong financial performance with a 7.93% revenue growth rate and a 33.67% net margin, but faces challenges with a low ROA of 0.87%.

Portfolio Pulse from Benzinga Insights

October 07, 2024 | 5:00 pm

Mizuho analyst John Roberts maintains a Neutral rating on Arcadium Lithium (NYSE:ALTM) but raises the price target from $3 to $4.3.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 4:59 pm

U.S. stocks traded lower with the Dow Jones falling over 200 points. Scholar Rock shares surged 310% after positive clinical trial results. AstraZeneca entered a licensing agreement with CSPC Pharmaceutical. Duckhorn Portfolio shares rose 102% following strong earnings and acquisition news.

Portfolio Pulse from Avi Kapoor

October 07, 2024 | 4:00 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.